The fast pace of innovation in IT offers compelling investment opportunities
Truffle Capital is a pioneer investor in the exciting field of Energy
Biotechnology has radically transformed medicine over the past 25 years
DenyAll opens office in Singapore, in support of Asian expansion
Momac Survey confirms users are demanding more on-device account services
Prosep reports 2012 annual and 2013 first quarter Financial results
Carmat has obtained the approval to proceed with the first human implantations of its bioprosthetic artificial heart at four renowned international cardiac surgery centers in four countries.
Neovacs receives payment of €415K from Oseo for the Tracker programme
Agreement with the Silesian Center for Heart Diseases in Zabrze, Poland, to perform implants of Carmat’s bioprosthetic artificial heart
Agreement with the Prince Sultan Cardiac Center in Riyadh, Kingdom of Saudi Arabia, to perform implants of Carmat’s bioprosthetic artificial heart
Agreement with the University Medical Centre in Ljubljana, Slovenia, to perform implants of Carmat’s bioprosthetic artificial heart.
Agreement with St Pierre University Hospital in Brussels, Belgium, to perform implantations of Carmat’s bioprosthetic artificial heart.